FDA Places Clinical Hold on Gilead's HIV Studies, Stock Down

• click to rate

  Posted by Two Blokes Jun 11 - Filed in Stock - 7 views
  
  GILD slides 2.6% after FDA halts trials for HIV candidates, GS-1720 and GS-4182, over safety concerns in patients.